FinTrust Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $873K | Buy |
11,200
+504
| +5% | +$39.3K | 0.15% | 127 |
|
|
2024
Q2 | $834K | Buy |
10,696
+2,073
| +24% | +$162K | 0.15% | 126 |
|
|
2024
Q1 | $584K | Buy |
8,623
+60
| +0.7% | +$4.07K | 0.11% | 157 |
|
|
2023
Q4 | $577K | Sell |
8,563
-666
| -7% | -$44.9K | 0.11% | 160 |
|
|
2023
Q3 | $625K | Sell |
9,229
-3,444
| -27% | -$233K | 0.14% | 145 |
|
|
2023
Q2 | $892K | Hold |
12,673
| – | – | 0.21% | 115 |
|
|
2023
Q1 | $873K | Hold |
12,673
| – | – | 0.21% | 114 |
|
|
2022
Q4 | $859K | Buy |
12,673
+3,354
| +36% | +$227K | 0.21% | 116 |
|
|
2022
Q3 | $511K | Buy |
9,319
+3,972
| +74% | +$218K | 0.13% | 157 |
|
|
2022
Q2 | $353K | Sell |
5,347
-13
| -0.2% | -$858 | 0.09% | 193 |
|
|
2022
Q1 | $355K | Buy |
5,360
+5,000
| +1,389% | +$331K | 0.08% | 203 |
|
|
2021
Q4 | $21K | Hold |
360
| – | – | 0.01% | 727 |
|
|
2021
Q3 | $22K | Buy |
360
+126
| +54% | +$7.7K | 0.01% | 710 |
|
|
2021
Q2 | $14K | Buy |
234
+39
| +20% | +$2.33K | ﹤0.01% | 823 |
|
|
2021
Q1 | $10K | Buy |
195
+116
| +147% | +$5.95K | ﹤0.01% | 879 |
|
|
2020
Q4 | $4K | Buy |
79
+41
| +108% | +$2.08K | ﹤0.01% | 955 |
|
|
2020
Q3 | $2 | Sell |
38
-96
| -72% | -$5 | ﹤0.01% | 1044 |
|
|
2020
Q2 | $7K | Sell |
134
-86
| -39% | -$4.49K | ﹤0.01% | 767 |
|
|
2020
Q1 | $10K | Sell |
220
-19
| -8% | -$864 | ﹤0.01% | 742 |
|
|
2019
Q4 | $12K | Sell |
239
-32
| -12% | -$1.61K | ﹤0.01% | 709 |
|
|
2019
Q3 | $12K | Sell |
271
-142
| -34% | -$6.29K | ﹤0.01% | 702 |
|
|
2019
Q2 | $17K | Sell |
413
-320
| -44% | -$13.2K | 0.01% | 632 |
|
|
2019
Q1 | $30K | Buy |
733
+7
| +1% | +$286 | 0.01% | 492 |
|
|
2018
Q4 | $28K | Buy |
+726
| New | +$28K | 0.01% | 496 |
|